Log in

Relevant bibliographies by topics / Therapeutic use / Journal articles

To see the other types of publications on this topic, follow the link: Therapeutic use.

Journal articles on the topic 'Therapeutic use'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Therapeutic use.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Alvarez, Vincent, Jong Woo Lee, Frank W. Drislane, et al. "Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison." Epilepsia 56, no. 8 (2015): 1275–85. https://doi.org/10.1111/epi.13056.

Full text

Abstract:

OBJECTIVE: Benzodiazepines (BZD) are recommended as first-line treatment for status epilepticus (SE), with lorazepam (LZP) and midazolam (MDZ) being the most widely used drugs and part of current treatment guidelines. Clonazepam (CLZ) is also utilized in many countries; however, there is no systematic comparison of these agents for treatment of SE to date. METHODS: We identified all patients treated with CLZ, LZP, or MDZ as a first-line agent from a prospectively collected observational cohort of adult patients treated for SE in four tertiary care centers. Relative efficacies of CLZ, LZP, and

APA, Harvard, Vancouver, ISO, and other styles

2

Varsha*, Robin George Shashank D. "Saroglitazar's Therapeutic Use in Metabolic Syndrome and Nafld." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 3200–3207. https://doi.org/10.5281/zenodo.15111106.

Full text

Abstract:

Background: Saroglitazar is a novel anti-diabetic drug with combined PPAR-α/-γ agonistic activity. It was developed domestically by an Indian company called Zydus Cadila in 2001, and after numerous preclinical and clinical trials, it received regulatory approval from the Indian drug controller and regulatory authority called DCGI, India in June 2013. Non-alcoholic Fatty Liver Disease, diabetes, obesity, dyslipidemia, and cardiovascular disease are all grouped together as metabolic syndrome, and these conditions are caused by a sedentary and western lifestyle. Type 2 diabetes mellit

APA, Harvard, Vancouver, ISO, and other styles

3

Dvorak, J. "Therapeutic use exemption." British Journal of Sports Medicine 40, Supplement 1 (2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Nadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince, and J. E. Bowen. "THERAPEUTIC MODALITY USE." Medicine & Science in Sports & Exercise 33, no. 5 (2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Neekhra, Sachin, Himani Awasthi, and DCP Singh. "Potential Therapeutic use of Streblus asper: A Review." International Journal of Research and Development in Pharmacy & Life Sciences 6, no. 7 (2017): 2845–49. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(7).2845-2849.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Pradhan, Leena, Nicholas D. Andersen, Christoph Nabzdyk, Frank W. LoGerfo, and Aristidis Veves. "Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions." US Endocrinology 00, no. 01 (2007): 68. http://dx.doi.org/10.17925/use.2007.00.1.68.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Alvarez, Vincent, Jean-Marie Januel, Bernard Burnand, and Andrea O. Rossetti. "Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam." Epilepsia 52, no. 7 (2011): 1292–96. https://doi.org/10.1111/j.1528-1167.2011.03056.x.

Full text

Abstract:

PURPOSE: Phenytoin (PHT), valproic acid (VPA), or levetiracetam (LEV) are commonly used as second-line treatment of status epilepticus (SE), but comparative studies are not available. METHODS: Among 279 adult SE episodes identified prospectively in our tertiary care hospital over 4 years, we retrospectively identified 187 episodes in which PHT, VPA, or LEV were given after benzodiazepines. Patients with postanoxic SE were not included. Demographics, clinical SE features, failure of second-line treatment to control SE, new handicap, and mortality at hospital discharge were assessed. Uni- and mu

APA, Harvard, Vancouver, ISO, and other styles

8

Gallagher, Lisa M., and Francois Bethoux. "Therapeutic use of the Arts for Patients with Multiple Sclerosis." US Endocrinology 13, no. 02 (2017): 82. http://dx.doi.org/10.17925/use.2017.13.02.82.

Full text

Abstract:

People with multiple sclerosis (MS) face a wide variety of physical, emotional, and social challenges. A multidisciplinary comprehensive care approach is recommended for the management of MS and its consequences, and non-traditional treatments are increasingly considered by patients and health care providers, particularly for the promotion of wellness in the context of this chronic disease. Previous research has demonstrated the benefits of the therapeutic arts (art therapy, dance and movement therapy, and music therapy) in addressing some of the physiological, psychological, cognitive, social

APA, Harvard, Vancouver, ISO, and other styles

9

Groeneweg, Stefan, Robin P. Peeters, Theo J. Visser, and W. Edward Visser. "Diagnostic and Therapeutic Challenges in the Allan—Herndon—Dudley Syndrome." US Endocrinology 12, no. 02 (2016): 90. http://dx.doi.org/10.17925/use.2016.12.02.90.

Full text

Abstract:

Thyroid hormone (TH) is important for normal brain development. The TH transporter protein monocarboxylate transporter 8 (MCT8) is crucial to maintain adequate TH levels in the brain during development and throughout life. Mutations in MCT8 result in the Allan–Herndon–Dudley syndrome (AHDS), which is characterized by a severe delay in neurocognitive development, combined with abnormal serum thyroid function tests (TFTs). The combination of an increased (F)T3 and decreased (F)T4 and rT3 serum levels are characteristic for the presence of AHDS in male patients with moderate to severe delay in ne

APA, Harvard, Vancouver, ISO, and other styles

10

Kundu, Piyali, Taiyeba Tahira, and P. B Kar Mahapatra. "Multidimensional Therapeutic Use of 'Talisadichurna': An Ayurvedic Literary Review." International Journal of Science and Research (IJSR) 11, no. 6 (2022): 82–85. http://dx.doi.org/10.21275/sr22527162152.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Tan, Robert S., Chris Ojeih, and Maurita Carrejo. "Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism." US Endocrinology 00, no. 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Tan, Robert S., Chris Ojeih, and Maurita Carrejo. "Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism." US Endocrinology 00, no. 01 (2005): 84. http://dx.doi.org/10.17925/use.2005.00.01.84.

Full text

Abstract:

Memory problems late in life are common and are often easy to recognize. Hypogonadism in older men is not as readily identified, but it is also frequently a part of aging. Androgens, such as testosterone, have important hormonal influences on the brain and may prevent and possibly treat cognitive loss, including age-associated memory loss, mild cognitive impairment (MCI), and perhaps even Alzheimer’s disease (AD).There is support from small, prospective clinical trials that suggest the role of testosterone in improving cognitive function in normal men as well as hypogonadal men with AD. This i

APA, Harvard, Vancouver, ISO, and other styles

13

Rodriguez, Mariano, Juan Munoz-Castaneda, and Yolanda Almaden. "Therapeutic Use of Calcitriol." Current Vascular Pharmacology 12, no. 2 (2014): 294–99. http://dx.doi.org/10.2174/15701611113119990021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Wall, Jenny, Sally Davis, and Samantha Ridgway. "Cannabis: its therapeutic use." Nursing Standard 16, no. 10 (2001): 39–44. http://dx.doi.org/10.7748/ns2001.11.16.10.39.c3123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Hogaboam, Cory, Cynthia Bone-Larson, Akihiro Matsukawa, et al. "Therapeutic Use of Chemokines." Current Pharmaceutical Design 6, no. 6 (2000): 651–63. http://dx.doi.org/10.2174/1381612003400605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Whall, Ann L. "THERAPEUTIC USE OF SELF." Journal of Gerontological Nursing 14, no. 2 (1988): 38–39. http://dx.doi.org/10.3928/0098-9134-19880201-09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jones, Janet. "Therapeutic use of metaphor." Nursing Standard 6, no. 11 (1991): 30–32. http://dx.doi.org/10.7748/ns.6.11.30.s34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Hebert, Steven C. "Therapeutic Use of Calcimimetics." Annual Review of Medicine 57, no. 1 (2006): 349–64. http://dx.doi.org/10.1146/annurev.med.57.121304.131328.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;, &NA;. "Therapeutic Use for Nicotine?" AJN, American Journal of Nursing 94, no. 6 (1994): 50. http://dx.doi.org/10.1097/00000446-199406000-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Pridmore, Saxby. "Therapeutic use of rTMS." Nature Reviews Neuroscience 8, no. 10 (2007): 808. http://dx.doi.org/10.1038/nrn2169-c1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Ridding, Michael C., and John C. Rothwell. "Therapeutic use of rTMS." Nature Reviews Neuroscience 8, no. 10 (2007): 808. http://dx.doi.org/10.1038/nrn2169-c2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

DE Gaudio, A. R. "Therapeutic Use of Albumin." International Journal of Artificial Organs 18, no. 4 (1995): 216–24. http://dx.doi.org/10.1177/039139889501800407.

Full text

Abstract:

The clinical use of albumin solutions is a controversial issue, that involves albumin as a volume plasma expander, a supplement of total parenteral nutrition and a substance with pharmacological properties. The aim of this review is to show the present role of albumin in the clinical setting. We reviewed experimental and clinical data collected by the Medline System and the bibliographies of relevant articles. Experimental studies were selected on the basis of their historical value and applicability (hypothetical use, correct use) to the clinical setting. At present, it is possible to assert

APA, Harvard, Vancouver, ISO, and other styles

23

Soothill, James, Catherine Hawkins, Erik Änggår, and David Harper. "Therapeutic use of bacteriophages." Lancet Infectious Diseases 4, no. 9 (2004): 544–45. http://dx.doi.org/10.1016/s1473-3099(04)01127-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Grotenhermen, Franjo. "Therapeutic use of cannabis." Lancet 351, no. 9104 (1998): 758–59. http://dx.doi.org/10.1016/s0140-6736(05)78538-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Winblad, Bengt, Mario Fioravanti, Tomas Dolezal, et al. "Therapeutic Use of Nicergoline." Clinical Drug Investigation 28, no. 9 (2008): 533–52. http://dx.doi.org/10.2165/00044011-200828090-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Stiehm, E. Richard, Jordan S. Orange, Mark Ballow, and Heather Lehman. "Therapeutic Use of Immunoglobulins." Advances in Pediatrics 57, no. 1 (2010): 185–218. http://dx.doi.org/10.1016/j.yapd.2010.08.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Grotenhermen, Franjo. "Cannabinoids for Therapeutic Use." American Journal of Drug Delivery 2, no. 4 (2004): 229–40. http://dx.doi.org/10.2165/00137696-200402040-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Shore, Lisa B. "Therapeutic Use of Touch." Pediatric Physical Therapy 9, no. 1 (1997): 41. http://dx.doi.org/10.1097/00001577-199700910-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Goelitz, Ann, and Abigail Stewart Kahn. "Therapeutic Use of Space." Journal of Creativity in Mental Health 2, no. 4 (2008): 31–44. http://dx.doi.org/10.1300/j456v02n04_04.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Balazs, Endre A. "Therapeutic use of hyaluronan." Structural Chemistry 20, no. 2 (2009): 341–49. http://dx.doi.org/10.1007/s11224-009-9435-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Salvi, Mario, Guia Vannucchi, and Paolo Beck-Peccoz. "Rituximab for the Treatment of Graves’ Orbitopathy." US Endocrinology 07, no. 02 (2011): 130. http://dx.doi.org/10.17925/use.2011.07.02.130.

Full text

Abstract:

The contribution of B-cells to human autoimmune disease has recently been underscored because of the therapeutic benefit of B-cell depleting therapies. B-cells are involved in the production of autoantibodies, and in CD4+ T-cell activation, control of T-cell function, and inflammation through cytokine production. B-cells are also important antigen-presenting cells. Rituximab (RTX) has been used off-label in various autoimmune disorders and has been shown to effectively deplete mature and memory CD20+ B-cells, but not long-lived plasma cells. The rationale behind the use of RTX in Graves’ disea

APA, Harvard, Vancouver, ISO, and other styles

32

Kranz, Florence. "Die Therapeutin als Werkzeug in der Beziehungsgestaltung – Therapeutic Use of Self." ergopraxis 18, no. 04 (2025): 34–37. https://doi.org/10.1055/a-2510-7600.

Full text

Abstract:

Wenn wir mit Klient*innen arbeiten, hängt der Therapieerfolg nicht nur von fachlichen Kompetenzen und Konzepten ab. Entscheidend ist auch, wie wir die therapeutische Beziehung gestalten und uns selbst in den Kontakt einbringen. Der Artikel nimmt den Einsatz der eigenen Person und die Interaktion mit den Klient*innen unter die Lupe.

APA, Harvard, Vancouver, ISO, and other styles

33

Alam, Md Khorshed, Md Obydul Hoq, and Md Shahab Uddin. "Therapeutic use of Withania somnifera." Asian Journal of Medical and Biological Research 2, no. 2 (2016): 148–55. http://dx.doi.org/10.3329/ajmbr.v2i2.29004.

Full text

Abstract:

Withania somnifera (L) Dunal is commonly called as Ashwagandha/Asgand and it belongs to the family Solanaceae. It is a well known medicinal plant widely used in the treatment of many clinical conditions in Indian subcontinent. It is an important medicinal plant commonly known as Asgand which has been used either single or in combination with other drugs in Unani as well as Ayurvedic system of medicine for centuries. It has been described by Dioscorides (78 AD) in his book Kitab-ul-Hashaish. Asgand consists of the roots of Withania somnifera which has various therapeutic actions such as anti

APA, Harvard, Vancouver, ISO, and other styles

34

Hossain, Md Tofazzal, and Md Obydul Hoq. "Therapeutic use of Adhatoda vasica." Asian Journal of Medical and Biological Research 2, no. 2 (2016): 156–63. http://dx.doi.org/10.3329/ajmbr.v2i2.29005.

Full text

Abstract:

Adhatoda vasica Nees belonging to family Acanthaceae, commonly known as Adosa, is found many regions of India and throughout the world, with a multitude of uses in traditional Unani and Ayurvedic systems of medicine. It is also called Vasaka. It is a well-known herb in indigenous systems of medicine for its beneficial effects, particularly in bronchitis. Vasaka leaves, bark, the root bark, the fruit and flowers are useful in the removal of intestinal parasites. Vasaka herb is used for treating cold, cough, chronic bronchitis and asthma. In acute stages of bronchitis, vasaka gives unfailing r

APA, Harvard, Vancouver, ISO, and other styles

35

Nasser, Abdullah. "Ready-to-use therapeutic foods." University of Western Ontario Medical Journal 83, no. 2 (2014): 26–27. http://dx.doi.org/10.5206/uwomj.v83i2.4440.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Medeiros, Aldo Cunha, and Vanessa De Fátima Lima de Paiva Medeiros. "Therapeutic use of coconut water." JOURNAL OF SURGICAL AND CLINICAL RESEARCH 3, no. 2 (2013): 83. http://dx.doi.org/10.20398/jscr.v3i2.3570.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Poulton, James L., and Donald S. Strassberg. "The Therapeutic Use of Reminiscence." International Journal of Group Psychotherapy 36, no. 3 (1986): 381–98. http://dx.doi.org/10.1080/00207284.1986.11490910.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Bell, Susan Givens. "The Therapeutic Use of Honey." Neonatal Network 26, no. 4 (2007): 247–51. http://dx.doi.org/10.1891/0730-0832.26.4.247.

Full text

Abstract:

THE ANCIENTS WROTE OF THE healing properties of honey. A Sumerian tablet, possibly dated 3000 BCE, documents the treatment of an infected skin ulcer with honey. An Egyptian papyrus dated around 2000 BCE notes the use of honey to treat a gaping wound penetrating to the bone near the eyebrow. Aristotle (384–322 BCE) wrote about the use of honey to treat wounds and sore eyes. As with those of other natural substances, the healing benefits of honey were passed from generation to generation. Honey continues to be a popular medicine throughout the world, except in the U.S.1

APA, Harvard, Vancouver, ISO, and other styles

39

Salladay, Susan A. "Should Christians Use Therapeutic Touch?" Christian bioethics: Non-Ecumenical Studies in Medical Morality 8, no. 1 (2002): 25–42. http://dx.doi.org/10.1093/chbi.8.1.25.8756.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Ehrenfeld, M., and R. Bergman. "The Therapeutic Use of Dolls." Perspectives in Psychiatric Care 31, no. 4 (2009): 21–22. http://dx.doi.org/10.1111/j.1744-6163.1995.tb00484.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Bechler-Karsch, Abby. "The Therapeutic Use of Music." Worldviews on Evidence-Based Nursing E1, no. 1 (1994): 23–33. http://dx.doi.org/10.1111/j.1524-475x.1993.00023.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Brock, Medina. "The Therapeutic Use of Clay." British Journal of Occupational Therapy 54, no. 1 (1991): 13–15. http://dx.doi.org/10.1177/030802269105400108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Krenning, Eric P., and Marion de Jong. "Therapeutic use of radiolabelled peptides." Annals of Oncology 11 (2000): 267–72. http://dx.doi.org/10.1093/annonc/11.suppl_3.267.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman, and Gary Holden. "The Therapeutic Use of Technology." American Journal of Nursing 98, no. 12 (1998): 32–35. http://dx.doi.org/10.1097/00000446-199812000-00037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman, and Gary Holden. "The Therapeutic Use of Technology." AJN, American Journal of Nursing 98, no. 12 (1998): 32–35. http://dx.doi.org/10.1097/00000446-199898120-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Andrews, A. "Therapeutic use of bovine somatotrophin." Veterinary Record 132, no. 21 (1993): 540. http://dx.doi.org/10.1136/vr.132.21.540-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Salladay, S. A. "Should Christians Use Therapeutic Touch?" Christian Bioethics 8, no. 1 (2002): 25–42. http://dx.doi.org/10.1076/chbi.8.1.25.8756.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Little, John. "The therapeutic use of ‘no’." Australasian Psychiatry 23, no. 2 (2015): 136–38. http://dx.doi.org/10.1177/1039856214568225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Cohen, Susan M., Mary Ellen Rousseau, and Elizabeth H. Robinson. "Therapeutic Use of Selected Herbs." Holistic Nursing Practice 14, no. 3 (2000): 59–68. http://dx.doi.org/10.1097/00004650-200004000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Cazenave, S. O. S., C. L. Correa, E. C. Freitas, and L. Matias. "Unsanctioned use of therapeutic drugs." Toxicology Letters 95 (July 1998): 122. http://dx.doi.org/10.1016/s0378-4274(98)80483-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!